The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

Blockbuster drugs rake in at least $1 billion in ... will end at the beginning of August. Sales of Merck's Covid antiviral pill, Lagevrio, also fell 40% to $383 million during the quarter.

The company's immunotherapy drug Keytruda recorded $7.43 billion ... will end at the beginning of August. Sales of Merck's Covid antiviral pill, Lagevrio, also fell 40% to $383 million during ...

Merck is committed to supporting exceptional biotech companies to both kickstart and streamline their journey from discovery ...

Merck & Co. Inc.'s stock fell 3% Thursday, after the drug company beat profit and sales estimates for the third quarter, but lowered guidance due to charges stemming from deals with partners Curon ...